AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9621474 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 intracervical (PGE2 IC) gel
Number of subjects: 100
Study 9621474 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin infusion and artificial rupture of membrane (ARM)
Number of subjects: 100
Study 1789814 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg once daily
Number of subjects: 0
Study 1789814 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg b.i.d.
Number of subjects: 0
Study 7014318 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate endoscopy
Number of subjects: 100
Study 7014318 — intervention group
Group type: COMPARATOR
Intervention: Next-day endoscopy
Number of subjects: 100
Study 31920057 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis solution
Number of subjects: 30
Study 31920057 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 30
Study 31920057 — intervention group
Group type: COMPARATOR
Intervention: Alkaline peroxide
Number of subjects: 30
Study 28596379 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained Inflation (SI)
Number of subjects: 162
Study 28596379 — intervention group
Group type: COMPARATOR
Intervention: Positive Pressure Ventilation (PPV)
Number of subjects: 162
Study 25123978 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day
Number of subjects: 1079
Study 25123978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1079
Study 23975566 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiScope
Number of subjects: 400
Study 23975566 — intervention group
Group type: COMPARATOR
Intervention: Macintosh
Number of subjects: 400
Study 22224109 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium profile 3 and ultra filtration profile 3
Number of subjects: 24
Study 22224109 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold dialysate
Number of subjects: 24
Study 22224109 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sodium profile 3, ultra filtration profile 3, and cold dialysate
Number of subjects: 24
Study 19033829 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based family treatment program
Number of subjects: 9
Study 17146317 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin and mineral supplementation (Vm group)
Number of subjects: 22
Study 17146317 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl group)
Number of subjects: 22
Study 17146317 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Vm and Pl)
Number of subjects: 22
Study 12876635 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol-1beta combined with micronised progesterone (n=63)
Number of subjects: 196
Study 12876635 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol-1beta combined with micronised progesterone (n=68)
Number of subjects: 196
Study 12876635 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=65)
Number of subjects: 196
Study 10981839 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinking about mortality
Number of subjects: 0
Study 10981839 — intervention group
Group type: COMPARATOR
Intervention: Not thinking about mortality
Number of subjects: 0
Study 8825538 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxacurium 0.05 mg.kg‐1 (Group 1)
Number of subjects: 20
Study 8825538 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxacurium 0.075 mg.kg‐1 (Group 2)
Number of subjects: 20
Study 1909485 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisuride alone (1.43 +/- 0.10 mg)
Number of subjects: 20
Study 1909485 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisuride plus selegiline (10 mg/day)
Number of subjects: 20
Study 1909485 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus lisuride
Number of subjects: 20
Study 6195911 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol, 40 mg every 8 hours
Number of subjects: 21
Study 6195911 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol, 300 mg every 8 hours
Number of subjects: 21
Study 6195911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 31934845 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation plus usual care
Number of subjects: 449
Study 31934845 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 449
Study 30865291 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly forming bone graft (NFBG) and coronally advanced flap (CAF)
Number of subjects: 0
Study 30865291 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG) and CAF (control)
Number of subjects: 0
Study 28952704 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with 5-reductase inhibitors and blockers
Number of subjects: 0
Study 28952704 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 24438381 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic version of the web-based computer-tailored nutrition education intervention
Number of subjects: 0
Study 24438381 — intervention group
Group type: EXPERIMENTAL
Intervention: Plus version of the web-based computer-tailored nutrition education intervention
Number of subjects: 0
Study 24438381 — intervention group
Group type: COMPARATOR
Intervention: Generic nutrition information control condition
Number of subjects: 0
Study 22926322 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental multilevel intervention designed to improve quality of care and resident outcomes
Number of subjects: 29
Study 22926322 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement methods and activities
Number of subjects: 29
Study 22926322 — intervention group
Group type: EXPERIMENTAL
Intervention: Leadership commitment to communication and active participation
Number of subjects: 29
Study 19192047 — intervention group
Group type: EXPERIMENTAL
Intervention: Burning Mouth Syndrome (BMS) patients
Number of subjects: 87
Study 19192047 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 87
Study 19192047 — intervention group
Group type: EXPERIMENTAL
Intervention: Menopausal or postmenopausal women with BMS
Number of subjects: 87
Study 19192047 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS patients
Number of subjects: 87
Study 17496655 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral cochlear implants
Number of subjects: 7
Study 15097238 — intervention group
Group type: EXPERIMENTAL
Intervention: Inner wall tracking using a new prototype 'wall tracking' system
Number of subjects: 39
Study 15097238 — intervention group
Group type: EXPERIMENTAL
Intervention: Inner wall tracking
Number of subjects: 39
Study 15097238 — intervention group
Group type: COMPARATOR
Intervention: Wall Track System (WTS)
Number of subjects: 39
Study 11784276 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondistally fixated (open kinetic chain) leg extensor resistance training
Number of subjects: 43
Study 11784276 — intervention group
Group type: COMPARATOR
Intervention: Distally fixated (closed kinetic chain) leg extensor resistance training
Number of subjects: 43
Study 9829845 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal samples and middle fractions of samples with anisocytosis
Number of subjects: 0
Study 9829845 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme fractions of elutriation profile
Number of subjects: 0
Study 9829845 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractions with largest red cells of microcytic series and smallest red cells of normo- and macrocytic samples
Number of subjects: 0
Study 7655254 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient managed learning and nurse directed teaching strategy
Number of subjects: 34
Study 7655254 — intervention group
Group type: COMPARATOR
Intervention: Conventional face‐to‐face methods
Number of subjects: 34
Study 2514458 — intervention group
Group type: EXPERIMENTAL
Intervention: Aseptic alginate impression material (Blueprint asept)
Number of subjects: 0
Study 4582563 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine alone
Number of subjects: 77
Study 4582563 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine combined with levodopa
Number of subjects: 77
Study 4582563 — intervention group
Group type: COMPARATOR
Intervention: Placebo instead of amantadine
Number of subjects: 77
Study 31829767 — intervention group
Group type: EXPERIMENTAL
Intervention: AS04-HPV-16/18 vaccine
Number of subjects: 32175
Study 31829767 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis-B virus vaccine (control)
Number of subjects: 32175
Study 30664075 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate antiretroviral therapy (ART)
Number of subjects: 0
Study 29185589 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab-gefitinib-WBRT
Number of subjects: 218
Study 29185589 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib-WBRT
Number of subjects: 218
Study 29185589 — intervention group
Group type: COMPARATOR
Intervention: WBRT
Number of subjects: 218
Study 25765099 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH + 150 rhIGF-1 (45/150 µg/kg)
Number of subjects: 180
Study 25765099 — intervention group
Group type: COMPARATOR
Intervention: rhGH alone (group A)
Number of subjects: 180
Study 25765099 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH + 50 rhIGF-1 (group B)
Number of subjects: 180
Study 25765099 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH + 100 rhIGF-1 (group C)
Number of subjects: 180
Study 23460356 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary wound closure
Number of subjects: 120
Study 23460356 — intervention group
Group type: COMPARATOR
Intervention: Delayed wound closure
Number of subjects: 120
Study 21219089 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecologically-oriented, strategy-based intervention for memory impairment
Number of subjects: 33
Study 16798651 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral deferiprone (L1)
Number of subjects: 0
Study 16798651 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous desferrioxamine (DFO)
Number of subjects: 0
Study 12782545 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day oral androstenedione
Number of subjects: 8
Study 12782545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 11243632 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-identical lipids in a petrolatum-rich cream base
Number of subjects: 0
Study 11243632 — intervention group
Group type: COMPARATOR
Intervention: Pure petrolatum
Number of subjects: 0
Study 9292679 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabecular aspiration technique with negative suction pressure ranging from 100 to 200 mm Hg
Number of subjects: 100
Study 9292679 — intervention group
Group type: COMPARATOR
Intervention: Control group (no trabecular aspiration)
Number of subjects: 100
Study 9292679 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabecular aspiration technique
Number of subjects: 100
Study 8306157 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% tetracaine hydrochloride
Number of subjects: 261
Study 8306157 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lignocaine hydrochloride
Number of subjects: 261
Study 8306157 — intervention group
Group type: COMPARATOR
Intervention: No local anaesthetic
Number of subjects: 261
Study 3792426 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (300 mg every 6 h)
Number of subjects: 12
Study 3792426 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg every 12 h)
Number of subjects: 12
Study 3792426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31567714 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 mg of 5% TXA in 100 mL of isotonic saline solution
Number of subjects: 157
Study 31567714 — intervention group
Group type: COMPARATOR
Intervention: 100 mL isotonic saline (control group)
Number of subjects: 157
Study 30287600 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium (100 mg/day; n=50)
Number of subjects: 100
Study 30287600 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=50)
Number of subjects: 100
Study 27513739 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer Assisted Femur First (CAS FF)
Number of subjects: 60
Study 27513739 — intervention group
Group type: COMPARATOR
Intervention: Conventional THR (CON)
Number of subjects: 60
Study 25297610 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU as retinol, single oral dose)
Number of subjects: 445
Study 25297610 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (1-2 mg/kg/d, daily for 5 days a week for 6 months)
Number of subjects: 445
Study 25297610 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined vitamin A and iron supplementation
Number of subjects: 445
Study 25297610 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no vitamin A or iron)
Number of subjects: 445
Study 21273285 — intervention group
Group type: EXPERIMENTAL
Intervention: Distalizing force applied to the maxillary canine (test tooth) using a 0.017 × 0.025 inch titanium‐molybdenum alloy archwire
Number of subjects: 16
Study 21273285 — intervention group
Group type: COMPARATOR
Intervention: Orthodontic appliance with no force applied to the contralateral canine (control tooth)
Number of subjects: 16
Study 20433527 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactotripeptides dosed twice daily
Number of subjects: 91
Study 20433527 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 20433527 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactotripeptides in treatment-naive patients
Number of subjects: 91
Study 20433527 — intervention group
Group type: COMPARATOR
Intervention: Placebo in treatment-naive patients
Number of subjects: 91
Study 19226067 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal-on-metal hip resurfacing
Number of subjects: 21
Study 19226067 — intervention group
Group type: COMPARATOR
Intervention: Ceramic-on-ceramic THA
Number of subjects: 21
Study 16202859 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 2 mg orally
Number of subjects: 26
Study 12390641 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's ibuprofen suspension (7.5 mg/kg, p.o.)
Number of subjects: 138
Study 12390641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 10357500 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated physician mammography reminders placed prominently in medical records
Number of subjects: 0
Study 10357500 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study 7790641 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary reinforcement plus instruction
Number of subjects: 40
Study 7790641 — intervention group
Group type: COMPARATOR
Intervention: Monetary reinforcement only
Number of subjects: 40
Study 7790641 — intervention group
Group type: COMPARATOR
Intervention: Instruction only
Number of subjects: 40
Study 7790641 — intervention group
Group type: COMPARATOR
Intervention: Repeat administration
Number of subjects: 40
Study 2088232 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (Doximycin) for 2 weeks
Number of subjects: 14
Study 2088232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 797088 — intervention group
Group type: EXPERIMENTAL
Intervention: Vistarin injections
Number of subjects: 250
Study 797088 — intervention group
Group type: COMPARATOR
Intervention: Varicocide injections
Number of subjects: 250
Study 30414219 — intervention group
Group type: EXPERIMENTAL
Intervention: Recapture Life (six-session group-based online cognitive-behavioural intervention)
Number of subjects: 61
Study 30414219 — intervention group
Group type: COMPARATOR
Intervention: Online peer-support group (control)
Number of subjects: 61
Study 30414219 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 61
Study 28430175 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib-lenalidomide-dexamethasone (KRd)
Number of subjects: 0
Study 28430175 — intervention group
Group type: COMPARATOR
Intervention: lenalidomide-dexamethasone (Rd)
Number of subjects: 0
Study 26327554 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary wing daylight (RW-D)
Number of subjects: 12
Study 26327554 — intervention group
Group type: COMPARATOR
Intervention: Rotary wing in total darkness using binocular NVG (RW-NVG)
Number of subjects: 12
Study 26327554 — intervention group
Group type: COMPARATOR
Intervention: Emergency room (ER) setting
Number of subjects: 12
Study 26327554 — intervention group
Group type: EXPERIMENTAL
Intervention: All scenarios
Number of subjects: 12
Study 24099141 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG biofeedback
Number of subjects: 24
Study 24099141 — intervention group
Group type: COMPARATOR
Intervention: Sham biofeedback
Number of subjects: 24
Study 21756768 — intervention group
Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 50
Study 21756768 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE plus RFA
Number of subjects: 50
Study 18283261 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 66
Study 18283261 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 66
Study 16533414 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed-dose oxygen-conserving device (PDOCD)
Number of subjects: 10
Study 16533414 — intervention group
Group type: COMPARATOR
Intervention: Continuous-flow oxygen
Number of subjects: 10
Study 16533414 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed-dose oxygen-conserving device (PDOCD) with sensitive triggering sensitivity
Number of subjects: 10
Study 12648029 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritalin LA 20 mg capsule
Number of subjects: 20
Study 12648029 — intervention group
Group type: COMPARATOR
Intervention: Concerta 18 mg tablet
Number of subjects: 20
Study 11197318 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nicotine patch (21 mg for 6 weeks, then 14 mg for weeks 7-8, and 7 mg for weeks 9-10)
Number of subjects: 421
Study 11197318 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 421
Study 8956919 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 400 mg/day
Number of subjects: 47
Study 8956919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 1573068 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day neonatal resuscitation education program
Number of subjects: 190
Study 3904817 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic feedback controlled oxytocin infusion system (AIS)
Number of subjects: 0
Study 3904817 — intervention group
Group type: COMPARATOR
Intervention: Standard labour ward protocols (control)
Number of subjects: 0
Study 31192719 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support intervention with three sessions of education on Kangaroo Mother Care (KMC)
Number of subjects: 24
Study 29424243 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirvetuximab soravtansine
Number of subjects: 0
Study 29424243 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice of chemotherapy
Number of subjects: 0
Study 26636929 — intervention group
Group type: EXPERIMENTAL
Intervention: CVC 100 mg
Number of subjects: 143
Study 26636929 — intervention group
Group type: EXPERIMENTAL
Intervention: CVC 200 mg
Number of subjects: 143
Study 26636929 — intervention group
Group type: COMPARATOR
Intervention: EFV 600 mg
Number of subjects: 143
Study 25237065 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary [TIMP‐2]•[IGFBP7] values of 0.3 or greater
Number of subjects: 154
Study 25237065 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary [TIMP‐2]•[IGFBP7] values of >2
Number of subjects: 154
Study 25237065 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutoff of ≤0.3 versus >0.3‐2
Number of subjects: 154
Study 25237065 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutoff of ≤0.3 versus >2
Number of subjects: 154
Study 25237065 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutoff of 2.0
Number of subjects: 154
Study 21870050 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic duodenojejunal bypass with sleeve (DJB)
Number of subjects: 57
Study 21870050 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Roux en Y gastric bypass
Number of subjects: 57
Study 20201841 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-guided pelvic floor muscle exercises (PG-PFME)
Number of subjects: 82
Study 20201841 — intervention group
Group type: COMPARATOR
Intervention: Instruction folder only (F-PFME)
Number of subjects: 82
Study 16868362 — intervention group
Group type: EXPERIMENTAL
Intervention: Red fluorescent light (700 lux)
Number of subjects: 12
Study 16868362 — intervention group
Group type: EXPERIMENTAL
Intervention: Green fluorescent light (700 lux)
Number of subjects: 12
Study 16868362 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue fluorescent light (700 lux)
Number of subjects: 12
Study 12752518 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,400 U of botulinum toxin type B (Myobloc)
Number of subjects: 39
Study 12752518 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,000 U of botulinum toxin type B (Myobloc)
Number of subjects: 39
Study 12752518 — intervention group
Group type: COMPARATOR
Intervention: Saline injections (control group)
Number of subjects: 39
Study 10789172 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery
Number of subjects: 0
Study 10789172 — intervention group
Group type: COMPARATOR
Intervention: Arthrocentesis
Number of subjects: 0
Study 10789172 — intervention group
Group type: COMPARATOR
Intervention: Lysis and lavage in the upper compartment of the TMJ
Number of subjects: 0
Study 9305418 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (0.8 mg)
Number of subjects: 0
Study 9305418 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (5 mg)
Number of subjects: 0
Study 9305418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9305418 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (0.8 mg) + Haloperidol (5 mg)
Number of subjects: 0
Study 9305418 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Haloperidol (5 mg)
Number of subjects: 0
Study 7818614 — intervention group
Group type: EXPERIMENTAL
Intervention: Dosing rules for phenytoin (PHT)
Number of subjects: 122
Study 3003315 — intervention group
Group type: EXPERIMENTAL
Intervention: Seronegative blood products
Number of subjects: 35